Composition comprising aflibercept and a variant thereof, and related methods and uses
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Mar 4, 2025
Grant Date -
N/A
app pub date -
May 30, 2024
filing date -
May 30, 2024
priority date (Note) -
In Force
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
Provided is a composition comprising aflibercept and a variant thereof, wherein the variant is a truncation variant with a truncated VEGF binding portion of aflibercept, and wherein the content of the truncation variant is less than or equal to about 20% by mass percentage. Also provided is a pharmaceutical formulation comprising the composition. Further, provided are a method for detecting the variant and use of the variant in quality inspection or quality control of an aflibercept-containing product.
First Claim
Other Claims data not available
Family
| Country | kind | publication No. | Filing Date | Type | Sub-Type |
|---|
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12Q Class
- 0 % this patent is cited more than
- < 1 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Sep 4, 2028 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Sep 4, 2032 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Sep 4, 2036 |